Back to MW MARSHALL WACE, LLP

ETONETON
9 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ETON PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 249,182 shares of ETON (ETON PHARMACEUTICALS INC), worth $9M as of 2026-Q2. The position was increased (+201.2% shares). ETON represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$9M

Current Shares

249,182

Total Value Change

+$8.5M

Total Shares Change

+164,270

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
249,182
+201.2%
$9M0.0%$36.20
44
2026-Q1
New
82,721
-
$2M0.0%$17.45
36
2025-Q1
Exited
0
-100.0%
$00.0%$13.02
0
2024-Q4
Increased
36,182
+75.3%
$481,9430.0%$13.03
36
2024-Q3
New
20,637
-
$123,8220.0%$5.80
31
2022-Q1
Exited
0
-100.0%
$00.0%$4.25
0
2021-Q4
New
92,092
-
$395,0000.0%$4.28
33
2021-Q3
Exited
0
-100.0%
$00.0%$5.04
0
2021-Q2
New
84,912
-
$523,0000.0%$6.25
33

Other major holders of ETON: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used